AI Summary

Researchers have observed a possible link between GLP‑1 medications such as Wegovy and Ozempic and increased incidence of alopecia, though robust evidence confirming the connection is still lacking. The observation highlights a growing concern about hair loss as a potential side effect of these widely used obesity and type‑2 diabetes treatments.

AI summaries can be wrong sometimes—always verify important details using the source article.